Relationship between carnitine, Fatty Acids and insulin resistance

Gynakologisch-geburtshilfliche Rundschau

Volumn 49, Issue 4, 2009, Pages 230-235

  Lohninger, Alfred ^a   Radler, U ^a   Jinniate, S ^b   Lohninger, S ^a   Karlic, H ^c   Lechner, S ^a   Mascher, D ^d   Tammaa, A ^b   Salzer, H ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b WILHELMINEN HOSPITAL   (Austria)

^c LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^d Pharm Analyt Laboratory GmbH   (Austria)

Author keywords

Acylcarnitines; Carnitine; Carnitine acetyltransferase; Carnitine palmitoyltransferase; Composition; Free fatty acids; Gene expression; Peripheral mononucleated cells; Plasma

Indexed keywords

CARNITINE; CARNITINE ACYLTRANSFERASE; CARRIER PROTEIN; FATTY ACID; MESSENGER RNA; PROTEIN OCTN2; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FATTY ACID BLOOD LEVEL; FATTY ACID OXIDATION; FEMALE; GLUCOSE OXIDATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INSULIN RESISTANCE; LIPID BLOOD LEVEL; PERIPHERAL BLOOD MONONUCLEAR CELL; PREGNANCY; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL;

CARNITINE; CARNITINE O-ACETYLTRANSFERASE; CARNITINE O-PALMITOYLTRANSFERASE; DIABETES, GESTATIONAL; FATTY ACIDS, NONESTERIFIED; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFANT, NEWBORN; INSULIN RESISTANCE; MONOCYTES; ORGANIC CATION TRANSPORT PROTEINS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; RNA, MESSENGER;

EID: 77953220004     PISSN: 10188843     EISSN: None     Source Type: Journal    
DOI: 10.1159/000301075     Document Type: Article

References (34)

1. Schoderbeck M, Auer B, Legenstein E, Genger H, Sevelda P, Salzer H, Marz R, Lohninger A: Pregnancy-related changes of carnitine and acylcarnitine concentrations of plasma and erythrocytes. J Perinat Med 1995; 23: 477-485.
2. Du X, Edelstein D, Obici S, Higham N, Zou MH, Brownlee M: Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation. J Clin Invest 2006; 116: 1071-1080.
3. Zammit VA, Waterman IJ, Topping D, Mc- Kay G: Insulin stimulation of hepatic triacylglycerol secretion and the etiology of insulin resistance. J Nutr 2001; 131: 2074-2077.
4. Steiber A, Kerner J, Hoppel CL: Carnitine: a nutritional, biosynthetic, and functional perspective. Mol Aspects Med 2004; 25: 455-473.
5. Ramsay RR, Zammit VA: Carnitine acyltransferases and their influence on CoA pools in health and disease. Mol Aspects Med 2004; 25: 475-493.
6. Ramsay RR, Naismith JH: A snapshot of carnitine acetyltransferase. Trends Biochem Sci 2003; 28: 343-346.
7. Van der Leij FR, Huijkman NC, Boomsma C, Kuipers JR, Bartelds B: Genomics of the human carnitine acyltransferase genes. Mol Genet Metab 2000; 71: 139-153.
8. Zeibig J, Karlic H, Lohninger A, Damsgaard R, Smekal G: Do blood cells mimic gene expression profile alterations known to occur in muscular adaptation to endurance training? Eur J Appl Physiol 2005; 95: 96-104.
9. Karlic H, Lohninger S, Koeck T, Lohninger A: Dietary L -carnitine stimulates carnitine acyltransferases in the liver of aged rats. J Histochem Cytochem 2002; 50: 205-212.
10. Brunner S, Kramar K, Denhardt DT, Hofbauer R: Cloning and characterization of murine carnitine acetyltransferase: evidence for a requirement during cell cycle progression. Biochem J 1997; 322: 403-410.
11. Brown NF, Weis BC, Husti JE, Foster DW, McGarry JD: Mitochondrial carnitine palmitoyltransferase I isoform switching in the developing rat heart. J Biol Chem 1995; 270: 8952-8957.
12. Lohninger A, Preis P, Linhart L, Sommoggy SV, Landau M, Kaiser E: Determination of plasma free fatty acids, free cholesterol, cholesteryl esters, and triacylglycerols directly from total lipid extract by capillary gas chromatography. Anal Biochem 1990; 186: 243-250.
13. Cederblad G, Lindstedt S: A method for the determination of carnitine in the picomole range. Clin Chim Acta 1972; 37: 235-243.
14. Muller DM, Seim H, Kiess W, Loster H, Richter T: Effects of oral L -carnitine supplementation on in vivo long-chain fatty acid oxidation in healthy adults. Metabolism 2002; 51: 1389-1391.
15. Wutzke KD, Lorenz H: The effect of L -carnitine on fat oxidation, protein turnover, and body composition in slightly overweight subjects. Metabolism 2004; 53: 1002-1006.
16. Bonnefont JP, Djouadi F, Prip-Buus C, Gobin S, Munnich A, Bastin J: Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. Mol Aspects Med 2004; 25: 495-520.
17. Karlic H, Lohninger A, Laschan C, Lapin A, Bohmer F, Huemer M, Guthann E, Rappold E, Pfeilstocker M: Downregulation of carnitine acyltransferases and organic cation transporter OCTN2 in mononuclear cells in healthy elderly and patients with myelodysplastic syndromes. J Mol Med 2003; 81: 435-442.
18. Mingrone G: Carnitine in type 2 diabetes. Ann NY Acad Sci 2004; 1033: 99-107.
19. Capaldo B, Napoli R, Di Bonito P, Albano G, Sacca L: Carnitine improves peripheral glucose disposal in non-insulin-dependent diabetic patients. Diabetes Res Clin Pract 1991; 14: 191-195.
20. Cox KB, Johnson KR, Wood PA: Chromosomal locations of the mouse fatty acid oxidation genes Cpt1a, Cpt1b, Cpt2, Acadvl, and metabolically related Crat gene. Mamm Genome 1998; 9: 608-610.
21. Ramsay RR, Gandour RD, van der Leij FR: Molecular enzymology of carnitine transfer and transport. Biochim Biophys Acta 2001; 1546: 21-43.
22. McGarry JD, Brown NF: The mitochondrial carnitine palmitoyltransferase system: from concept to molecular analysis. Eur J Biochem 1997; 244: 1-14.
23. Uenaka R, Kuwajima M, Ono A, Matsuzawa Y, Hayakawa J, Inohara N, Kagawa Y, Ohta S: Increased expression of carnitine palmitoyltransferase I gene is repressed by administering L -carnitine in the hearts of carnitine-deficient juvenile visceral steatosis mice. J Biochem 1996; 119: 533-540.
24. Horiuchi M, Kobayashi K, Tomomura M, Kuwajima M, Imamura Y, Koizumi T, Nikaido H, Hayakawa J, Saheki T: Carnitine administration to juvenile visceral steatosis mice corrects the suppressed expression of urea cycle enzymes by normalizing their transcription. J Biol Chem 1992; 267: 5032-5035.
25. Voehringer DW, Hirschberg DL, Xiao J, Lu Q, Roederer M, Lock CB, Herzenberg LA, Steinman L, Herzenberg LA: Gene microarray identification of redox and mitochondrial elements that control resistance or sensitivity to apoptosis. Proc Natl Acad Sci USA 2000; 97: 2680-2685.
26. Alesci S, De Martino MU, Mirani M, Benvenga S, Trimarchi F, Kino T, Chrousos GP: L -Carnitine: a nutritional modulator of glucocorticoid receptor functions. FASEB J 2003; 17: 1553-1555.
27. Bacurau RF, Navarro F, Bassit RA, Meneguello MO, Santos RV, Almeida AL, Costa Rosa LF: Does exercise training interfere with the effects of L -carnitine supplementation? Nutrition 2003; 19: 337-341.
28. Oey NA, den Boer ME, Ruiter JP, Wanders RJ, Duran M, Waterham HR, Boer K, van der Post JA, Wijburg FA: High activity of fatty acid oxidation enzymes in human placenta: implications for fetal-maternal disease. J Inherit Metab Dis 2003; 26: 385-392.
29. Volek JS, Kraemer WJ, Rubin MR, Gomez AL, Ratamess NA, Gaynor P: L -Carnitine L - tartrate supplementation favorably affects markers of recovery from exercise stress. Am J Physiol Endocrinol Metab 2002; 282:E474-E482.
30. Schaefer-Graf UM, Buchanan TA, Xiang A, Songster G, Montoro M, Kjos SL: Patterns of congenital anomalies and relationship to initial maternal fasting glucose levels in pregnancies complicated by type 2 and gestational diabetes. Am J Obstet Gynecol 2000; 182: 313-320.
31. Nachum Z, Ben-Shlomo I, Weiner E, Shalev E: Twice daily versus four times daily insulin dose regimens for diabetes in pregnancy: randomised controlled trial. BMJ 1999; 319: 1223-1227.
32. Garcia-Bournissen F, Feig DS, Koren G: Maternal- fetal transport of hypoglycaemic drugs. Clin Pharmacokinet 2003; 42: 303-313.
33. Lohninger A, Auer B, Lechner S, Salzer H: Prenatal effects of betamethasone- L -carnitine combinations on fetal rat lung. J Perinat Med 1996; 24: 591-599.
34. Lohninger A, Bock P, Dadak C, Feiks A, Kaiser E: Effect of carnitine on foetal rat lung dipalmitoyl phosphatidylcholine content and lung morphology: carnitine and lung surfactant I. J Clin Chem Clin Biochem 1990; 28: 313-318.